Table 3.
Challenge Groups | Macroscopic percentage (%) | Microscopic scores (0-22) | Trachea histopathology (0-8) |
---|---|---|---|
Homologous | |||
No MDA/NC | 0.4 ± 0.1a | 1.3 ± 0.1a | 0.1 ± 0.1a |
No MDA/H1N1 | 24.6 ± 2.3b | 15.2 ± 0.6b | 17 ± 03b,c |
WIV-MDA/H1N1 | 0.7 ± 0.4a,c | 5.3 ± 0.1c | 0.8 ± 0.6a,b |
EXP-MDA/H1N1 | 8.2 ± 1.8c | 10.4 ± 0.9d | 2.4 ± 0.2c |
Heterologous | |||
No MDA/NC | 0.4 ± 0.1a | 1.3 ± 0.1a | 0.1 ± 0.1a |
No MDA/H1N2 | 15.2 ± 2.0b | 13.4 ± 0.7b | 3.1 ± 0.5b |
WIV-MDA/H1N2 | 28.9 ± 8.1c | 13.4 ± 1.0b | 3.0 ± 0.6b |
EXP-MDA/H1N2 | 17.6 ± 2.0b,c | 12.0 ± 0.8b | 2.3 ± 0.4b |
NAT-MDA/H1N2 | 16.2 ± 2.9b | 17.7 ± 1.1c | 3.5 ± 0.6b |
Statistically significant differences in the same column identified with different lowercase letters (P ≤ 0.05).